FDA OKs Sanguina’s at-home test for anemia

People with anemia can now monitor levels of their hemoglobin with a simple test taken in the comfort of their homes. AnemoCheck Home, made by GRA-backed startup Sanguina, this month became the first at-home hemoglobin test kit to receive clearance by the U.S. Food and Drug Administration. Available only by prescription, the test involves a simple finger prick followed by the mixing of a blood droplet with a solution in a small tube; results are available in just two minutes. Sanguina, launched out of Georgia Tech, has received investment from GRA’s venture development program as well as GRA Venture Fund. • See Sanguina’s news release >